The Effect of USM-IAM-based Counselling

Not Applicable

Completed

• Conditions: Diabetes Type 2 on Insulin

• Registration Number: NCT05125185
• Lead Sponsor: Universiti Sains Malaysia

Brief Summary

According to the most current local data, the rate of patient's adherence to insulin injections is very low. A recent cross sectional study in Klinik Pakar Perubatan (KPP) Hospital Universiti Sains Malaysia (HUSM) among 355 patients with Type 2 diabetes treated with insulin showed only 19% of patients adhered to their insulin regime with the mean fasting plasma glucose of 10mmol/L and mean HbA1C of 10.0%. This condition may lead to undesirable health consequences.

Patients education has been showed to improved adherence. Among the 355 participants involved in the study, 82% of the patients have received consultation by diabetic educators yet their glycemic control were suboptimal. A new approaches using a module-based counseling that emphasized on adherence has been developed and the effectiveness of the counseling need to be evaluated.

Detailed Description

General objective: To determine the effect of USM-insulin adherence module (U-IAM)-based counseling on the insulin adherence, glycemic control and inflammatory markers in poorly-controlled type 2 diabetes mellitus patients on insulin therapy.

Specific objective:

1. To determine within group changes and between group differences of insulin adherence score (using IAQDM) between patients in intervention and control group at baseline, 3rd month and 6th month

2. To determine within group changes and between group differences of FBS and HbA1c between patients in intervention and control group at baseline, 3rd month and 6th month.

3. To determine within group changes and between group differences of HsCRP and VCAM-1 between patients in intervention and control group at baseline, 3rd month and 6th month.

4. To identify factors associated with nonadherence (before starting of intervention) among patients on insulin such as sociodemographic, SMBG and treatment factors.

Study Timeline

• Study Start: 2021-08-01
• Study First Submitted: 2021-10-27
• Study First Submitted QC: 2021-11-07
• Study First Posted: 2021-11-18
• Primary Completion: 2022-07-30
• Study Completion: 2022-07-30
• Status Verified: 2023-12
• Last Update Submitted: 2023-12-21
• Last Update Posted: 2023-12-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

• age between 18 to 65 years
• have been diagnosed with Type 2 Diabetes Mellitus
• Patients treated with insulin injections for at least 1 year on either basal insulin, basal plus prandial or basal bolus insulin
• HbA1c between 8 % and 15%

Exclusion Criteria

• do not understand Malay language or illiterate
• have severe diabetes complications such as chronic kidney disease, heart failure
• recurrent hypoglycemia or hypoglycemia unawareness
• body mass index (BMI) ≥ 40kg/m2

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change of HsCRP	6 months	change of HsCRP from baseline to 6 months
Change of insulin adherence score	6 months	Insulin adherence will be measured using insulin adherence questionnaire for diabetes mellitus. it contains 34 questions with minimum marks of 0 and maximum of 100 marks. The higher the marks, the higher the degree of adherence. Patient is considered adherence if they achieved marks of equal or more than 80
Change of HbA1c	6 months	change of HbA1c from baseline to 6 months
Change of VCAM-1	6 months	change of baseline from baseline to 6 months
Change of Fasting Blood Sugar	6 months	change of FBS from baseline to 6 months

Trial Locations

Locations (1)

Hospital Universiti Sains Malaysia; 🇲🇾 Kubang Kerian, Kelantan, Malaysia